2016 American Transplant Congress

June 11-15, 2016 in Boston, MA

View by Title View Sessions

View by Date

Tuesday, June 14, 2016

6:00pm-7:00pm: Living Donor Liver Transplantation for Children With Biliary Atresia in the Pediatric End-Stage Liver Disease Era: The Role of Age and Insurance Status.

J. Chu,^1,2 R. Annunziato,³ R. Aviles,³ R. Arnon.^1,2

Poster Session D: Pediatric Liver Transplantation • Halls C&D

6:00pm-7:00pm: Long Term Outcomes Following Antibody Mediated Rejection (AMR) in Renal Transplant Recipients.

R. Crew, S. Patel, H. Morris, M. Chiles, L. Ratner.

Poster Session D: Antibody Mediated Rejection: Session #2 • Halls C&D

6:00pm-7:00pm: Long-Term Outcomes in Epstein-Barr Virus (EBV)-Positive Patients Receiving Belatacept (Bela) or Cyclosporine (CsA) in BENEFIT-EXT.

S. Florman,¹ J. Medina Pestana,² M. del C Rial,³ L. Rostaing,⁴ D. Kuypers,⁵ A. Matas,⁶ T. Wekerle,⁷ J. Grinyó,⁸ U. Meier-Kriesche,⁹ M. Polinsky,⁹ H. Zhao,⁹ A. Durrbach.¹⁰

Poster Session D: Kidney Immunosuppression: Novel Agents • Halls C&D

6:00pm-7:00pm: Long-Term Outcomes in Pediatric Live-Donor Liver Transplantation.

N. Celik,¹ A. Ganoza,² F. Vyas,¹ J. Squires,³ V. Venkat,³ G. Bond,¹ K. Soltys,¹ R. Sindhi,¹ R. Squires,³ A. Humar,² G. Mazariegos.¹

Poster Session D: Pediatric Liver Transplantation • Halls C&D

6:00pm-7:00pm: Long-Term Renal Allograft Outcome After Parathyroidectomy.

M. Patecki, I. Scheffner, H. Haller, W. Gwinner.

Poster Session D: Poster Session II: Kidney Complications-Other • Halls C&D

6:00pm-7:00pm: Long-Term vs Short-Term Valganciclovir Prophylaxis Use for Cytomegalovirus and Epstein-Barr Virus Infections in Pediatric Living Related Liver Transplantation.

T. Ueno,¹ H. Yamanaka,¹ Y. Takama,¹ N. Tanaka,¹ Y. Tazuke,¹ K. Bessho,² H. Okuyama.¹

Poster Session D: Pediatric Liver Transplantation • Halls C&D

6:00pm-7:00pm: Low Pretransplant BMI/Weight and Changes in Posttransplant T Cell Exhaustion Levels Are Associated with Viremia/Viral Infection in Pediatric Kidney Transplantation in the First Post-Transplant Year – A Report from the IMPACT Study Consortium.

R. Ettenger,¹ H. Chin,² P. Grimm,³ K. Kesler,² E. Reed,⁴ M. Sarwal,⁵ B. Warshaw,⁶ E. Tsai,¹ A. Kirk.⁷

Poster Session D: Kidney-Pediatrics • Halls C&D

6:00pm-7:00pm: Management of Recurrent aHUS After Adult Kidney transplantation Despite Eculizumab Prophylaxis.

M. Morton,¹ R. Chinnadurai,¹ S. Ahmed,² A. Sharma,² T. Dutt,² S. Bhutani,¹ H. Denley,¹ T. Augustine,¹ T. Goodship,³ N. Sheerin,³ M. Picton.¹

Poster Session D: Poster Session II: Kidney Complications-Other • Halls C&D

6:00pm-7:00pm: Marked Alterations in Gene Expression in Peripheral Blood Leukocytes of Kidney Transplant (tx) Recipients Following Mycophenolic Acid (MPA) Treatment.

K. Sanghavi,¹ B. Wu,¹ C. Dorr,² A. Muthuswamy,² W. Guan,¹ D. Schladt,² R. Remmel,¹ D. Ilke,³ A. Matas,¹ A. Israni,² W. Oetting,¹ P. Jacobson.¹

Poster Session D: Poster Session II: Kidney Complications-Other • Halls C&D

6:00pm-7:00pm: Mass Cytometry Reveals NK Cell and T Cell Subsets in Pediatric Liver Transplant Patients with Acute Rejection.

A. Lau,^1,2 K. Haas,¹ T. Shawler,² C. Esquivel,² O. Martinez,² R. Castillo,¹ S. Krams.²

Poster Session D: Pediatric Liver Transplantation • Halls C&D